NASDAQ
Belite Bio, Inc (BLTE) has a current ratio of 50.02x as of Monday, May 25, 2026. This represents a 149.86% increase compared to its 12-month average of 20.02x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.